摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethylmorpholin-3-one | 45661-83-4

中文名称
——
中文别名
——
英文名称
N-ethylmorpholin-3-one
英文别名
4-ethyl-morpholin-3-one;4-Ethyltetrahydro-1,4-oxazin-3-one;N-ethylmorpholinone;4-ethylmorpholin-3-one
N-ethylmorpholin-3-one化学式
CAS
45661-83-4
化学式
C6H11NO2
mdl
——
分子量
129.159
InChiKey
ROBONFBGINEJFO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED 2-ALKYLIMIDAZOLYLCARBOXAMIDES AS PESTICIDES
    申请人:Bayer CropScience Aktiengesellschaft
    公开号:US20190119250A1
    公开(公告)日:2019-04-25
    The present invention relates to compounds of the general formula (I) in which Q, V, T, W, Y, L 1 , L 2 , L 3 and A have the meanings given in the description—and to a process for their preparation and to their use for controlling animal pests.
    本发明涉及一般式(I)中Q、V、T、W、Y、L1、L2、L3和A所表示的化合物,以及它们的制备方法和用于控制动物害虫的用途。
  • FACTOR XA INHIBITORS
    申请人:Song Yonghong
    公开号:US20070259924A1
    公开(公告)日:2007-11-08
    The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such a compound, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
    本发明涉及式(I)的化合物及其药学上可接受的盐、酯和前药,这些化合物是Xa因子的抑制剂。本发明还涉及用于制备这类化合物的中间体,含有这种化合物的药物组合物,预防或治疗一系列以不良血栓形成为特征的疾病的方法,以及抑制血样凝血的方法。
  • [EN] HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROARYLES SERVANT D'INHIBITEURS D'IRAK, ET LEURS UTILISATIONS
    申请人:MERCK PATENT GMBH
    公开号:WO2017049068A1
    公开(公告)日:2017-03-23
    The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    本发明涉及式(I)化合物及其药用可接受的组合物,作为IRAK抑制剂
  • LSD1 Inhibitors
    申请人:Mirati Therapeutics, Inc.
    公开号:US20170183308A1
    公开(公告)日:2017-06-29
    The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    本发明涉及抑制LSD1活性的化合物。具体而言,本发明涉及化合物、药物组合物和使用方法,例如使用本发明的化合物和药物组合物治疗癌症的方法。
  • Pesticidal carbamate esters of 5-oximino-1,3-oxazolidin-4-ones
    申请人:Union Carbide Corporation
    公开号:US04235902A1
    公开(公告)日:1980-11-25
    Certain 2-oximino-tetrahydro-1,4-oxazin-3-one and 5-oximino-1,3-oxazolidin-4-one carbamate esters exhibit outstanding miticidal, insecticidal and nematodicial activity; certain 2-oximino-tetrahydro-1,4-oxazin-3-ones and 5-oximino-1,3-oxazolidin-4-ones are useful intermediates in the preparation of pesticidally active carbamate compounds.
    某些2-氧代亚四氢-1,4-噁嗪-3-酮和5-氧代亚基-1,3-噁唑烷-4-酮氨基甲酸酯酯显示出卓越的杀螨、杀虫和杀线虫活性;某些2-氧代亚四氢-1,4-噁嗪-3-酮和5-氧代亚基-1,3-噁唑烷-4-酮是制备具有农药活性的氨基甲酸酯化合物的有用中间体。
查看更多